
Darizmetinib
CAS No. 2369583-33-3
Darizmetinib( —— )
Catalog No. M36482 CAS No. 2369583-33-3
Darizmetinib (HRX215, HRX-0215) is an MKK4 inhibitor. Inhibition of MKK4 leads to enhancement of the MKK7 and JNK1 signaling pathways, thereby activating the transcription factors ATF2 and ELK1, promoting cell proliferation and liver regeneration.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 236 | Get Quote |
![]() ![]() |
5MG | 367 | Get Quote |
![]() ![]() |
10MG | 588 | Get Quote |
![]() ![]() |
25MG | 1187 | Get Quote |
![]() ![]() |
50MG | 1822 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameDarizmetinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionDarizmetinib (HRX215, HRX-0215) is an MKK4 inhibitor. Inhibition of MKK4 leads to enhancement of the MKK7 and JNK1 signaling pathways, thereby activating the transcription factors ATF2 and ELK1, promoting cell proliferation and liver regeneration.
-
DescriptionDarizmetinib is an inhibitor of mitogen-activated protein kinase kinase (MAP2K).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
RecptorMAPK | Antiviral
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2369583-33-3
-
Formula Weight457.45
-
Molecular FormulaC21H17F2N5O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C1=NNC2=NC=C(C=C21)C=3C=CN=CC3)C4=CC=C(F)C(NS(=O)(=O)CCC)=C4F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Praefke B, et al. Preparation of pyrazolopyridines as protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death: World Intellectual Property Organization, WO2019149738. 2019-08-08.
molnova catalog



related products
-
mulberroside B
Antitussive, antiasthmatic, hypoglycemic, anti - tumor, treatment of gout.
-
Dehydrocorydaline ch...
Dehydrocorydaline chloride is an alkaloid with anti-inflammatory and anti-cancer activity. Can improve the activation of p38 MAPK.
-
ZINC05007751
ZINC05007751 is an effective inhibitor of NIMA-related kinase NEK6 (IC50 = 3.4 μM). ZINC05007751 is very selective against NEK1 and NEK6 with no significant activity observed against NEK2, NEK7, and NEK9.